Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/02/15 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
2 | |
| 04/01/15 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
4 | |
| 04/01/15 | 8-K | Current report filing |
|
10 | |
| 03/31/15 | 8-K | Current report filing |
|
34 | |
| 03/20/15 | 8-K | Current report filing |
|
4 | |
| 03/18/15 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 03/18/15 | 8-K | Current report filing |
|
6 | |
| 03/16/15 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
6 | |
| 03/16/15 | 8-K | Current report filing |
|
5 | |
| 03/12/15 | 8-K | Current report filing |
|
6 |
